Purpose Bilateral anorchia, either congenital or acquired, often requires testicular prostheses placement and testosterone supplementation. Several types of testosterone compounds and various modes of hormone delivery are currently used clinically, however, their pharmacokinetic properties are not ideal. In this study, we explored the possibility of creating hormone releasing testicular prostheses that could continuously supply and maintain physiologic levels of testosterone in vivo over time. Methods Chondrocytes, harvested from bovine articular cartilage, were seeded on testicular shaped polymer scaVolds at a concentration of 100 £ 10 6 ml
. The scaVolds were maintained in a bioreactor for 4 weeks to form cartilage tissue. Subsequently, testosterone enanthate (100 g) was injected into the central hollow space of each testicular prosthesis, and maintained for 40 weeks in culture. A sample of the medium was collected every 2 days for testosterone assays. Another group of ex vivo engineered testicular prostheses was implanted into the scrotal space of castrated athymic mice (n = 10). Intratesticular injection of testosterone enanthate was made into each prosthesis at a concentration of 100 g. Control groups consisted of animals with castration only (n = 8) and sham operations (n = 5). Testosterone levels were measured prior and 2 weeks after castration, 1 day after testosterone administration, and weekly up to 14 weeks. The engineered testicular prostheses were retrieved at sacriWce for histomorphological and immunocytochemical analyses. Results Milky white cartilage testicular protheses were formed by 4 weeks. The ex vivo prostheses showed an initial burst eVect of testosterone followed by a broad plateau for 16 weeks (>500 ng/dl) and a decreased level of testosterone until 40 weeks. The testosterone levels were physiologic throughout 40 weeks and the entire testosterone released was calculated as 60% of the injected volume. The circulating testosterone levels in the protheses implanted animals demonstrated a maximum peak on day 1 and a continued physiologic range during the entire study period. Histologically, the retrieved testicular implants showed mature chondrocytes with a hollow center in each prosthesis. Conclusion This study demonstrates that engineered cartilage testis can be created in bioreactors, can be implanted in vivo, and can release testosterone for a prolonged period.
restoration [1] [2] [3] [4] . Although implantation of testicular prostheses is not vital to patient's survival and daily activities, several studies have suggested that testicular implants lead to improved body image and personal satisfaction [4, 5] .
Silicone testicular prostheses, consisting of a silicone shell Wlled with silicone gel, were used clinically for several decades until a moratorium was imposed in 1992 due to safety concerns related to gel leakage [6] [7] [8] [9] . In addition, implantation of these prostheses has been associated with problems such as infection, inXammation and extrusion [8, 10] . Although saline Wlled silicone prostheses are currently being used clinically, long-term safety and biocompatibility have not yet been determined.
Although commercially available testicular prostheses are able to provide anatomical tissue restoration, normal testicular function, like production of testosterone cannot be achieved. As such, male hormone supplementation is necessary for the initiation and maintenance of secondary sexual characteristics in patients without testicular tissue [11] [12] [13] . Several types of testosterone compounds and various hormone delivery methods are currently being used clinically, but their pharmacokinetic properties are not entirely satisfactory [13] [14] [15] . The ideal substance for hormone supplementation should be long-acting, able to maintain consistent levels of circulating testosterone, economical, and it should not cause untoward eVects [13, 16, 17] .
The use of transdermal testosterone patches for this purpose has become popular due to the convenience of the method. However, the duration of action is relatively short and frequently requires an additional patch to maintain physiologic testosterone levels [18] [19] [20] . Moreover, dermatological problems are prevalent, which often require patients to seek other methods of testosterone delivery, such as oral or injection [13] . Oral testosterone pills are the Wrst line treatment and are administered daily. However, this method of administration is often associated with increased erythropoiesis [13, 21, 22] . Intramuscular injection of testosterone enanthate and testosterone undecanate is commonly used in patients because of the prolonged duration of action associated with these forms of testosterone. However, this method is associated with untoward eVects, like gynecomastia, and frequent injections (3-4 weeks) are required [13, 14, 17] .
We previously reported that autologous cartilage tissue can be engineered using chondrocytes seeded on biodegradable polymers [23] [24] [25] [26] [27] [28] . The polymers can be conWgured to achieve any shape or size, depending on the speciWc needs. We demonstrated that the engineered autologous cartilage tissue can be used to treat vesicoureteral reXux and incontinence, as penile prostheses, and as biological urethral stents [26] [27] [28] [29] . In this study, we examined the feasibility of using engineered cartilage tissue, with its associated elastic properties, for the creation of testicular prostheses. The use of autologous cells would diminish the risk of inXammatory and immunological reactions. We investigated the possibility of creating hormone releasing testicular prostheses that could continuously supply and maintain physiologic levels of circulating testosterone in vivo over time.
Materials and methods

Polymers
Unwoven sheets of polyglycolic acid polymers (density 58 mg/ml) were designed and conWgured into testis-shaped scaVolds with a central hollow space (0.4 cm in diameter and 1 cm in length). The polymers were composed of Wbers of 15 m in diameter and an interWber distance between 0 and 200 m with 95% porosity. The polymer scaVolds were designed to degrade via hydrolysis in 6-8 weeks. The resulting Xexible scaVold was coated with a liqueWed copolymer (poly-L-lactide-co-glycolide 50:50; Sigma; St Louis, MO; 80 mg/ml methylene chloride) in order to achieve adequate mechanical strengths to maintain structural integrity. The polymers were sterilized in ethylene oxide and placed under sterile conditions until cell delivery.
Cell isolation, culture and seeding Hyaline cartilage was obtained from the articular surfaces of calf shoulder. The shoulders were washed in Povidoneiodine 10% solution, and dissected into 2 to 3-mm tissue fragments. Chondrocytes were isolated under sterile conditions using a method reported previously [28] . BrieXy, the cartilage tissue fragments were digested in Ham's F-12 culture medium containing 3% type II collagenase for 6-12 h (Worthington Biochemical Corp., Lakewood, NJ). The recovered cells were rinsed in phosphate-buVered saline (PBS) and re-suspended in culture medium (Ham's F-12 containing 10% FBS, penicillin 100 U/cm 3 , and streptomycin 100 g/cm 3 , ascorbic acid 50 g/ml; Gibco; Grand Island, NY). Cell number and viability were determined by trypan blue exclusion under light microscopy. Chondrocytes were plated and grown in culture at 37°C in 5% CO 2 until a suYcient number of cells were obtained. Subsequently, the cells were trypsinized, collected, washed and counted for seeding.
Testicular prosthesis: in vivo tissue formation
Chondrocytes were seeded onto pre-formed poly-L-lactic acid coated polyglycolic acid polymers at a concentration of 50 £ 10 6 chondrocytes/cm 3 . A total of 32 poly-L-lactic acid-coated polyglycolic acid polymer scaVolds seeded with cells were implanted in the scrotal space of 16 athymic mice. A control group consisting of 16 polymer scaVolds without cells was implanted into the scrotal space of 8 animals. The animals were sacriWced at 1, 2, 3 and 6 months after implantation for analyses (n = 12 samples per time point; 4 with cells and 2 without cells).
Testicular prosthesis: in vitro functional studies
Chondrocytes were seeded onto ten pre-conWgured testisshaped polymers at a concentration of 100 £ 10 6 chondrocytes/cm 3 . Five days after seeding, the cell-polymer constructs were suspended freely and maintained in a rotating Xask bioreactor for 4 weeks to form cartilage tissue. Subsequently, testosterone enanthate (100 g) was injected into the central hollow space of each testicular prosthesis, and these prostheses were maintained for 40 weeks in culture. A sample of the medium was collected every 2 days and testosterone levels in the medium were measured.
Testicular prosthesis: in vivo functional studies
In addition to the aforementioned experiments, a separate group of ex vivo engineered testicular prostheses were prepared and implanted into the scrotal space of castrated athymic mice (n = 10). Testosterone enanthate (100 g) was injected into each prosthesis. The control groups consisted of animals with castration only (n = 8) and sham operations (n = 5). Blood samples from every animal were collected prior to and 2 weeks after castration, 1 day after testosterone administration, and weekly up to 16 weeks for circulating testosterone level measurement. The engineered testicular prostheses were retrieved at sacriWce for histomorphological and immunocytochemical analyses.
Histological and microscopic analyses
Five micron sections of formalin-Wxed paraYn-embedded tissues were cut and stained with hematoxylin and eosin (H&E), aldehyde fuschin-alcian blue, safranin-O, toluidine blue and Masson's trichrome. In addition, scanning electron microscopy (SEM) was performed to determine the distribution and extent of cartilage tissue formed within the polymer scaVolds prior to and at 1, 2, 3 and 6 months after implantation. Specimens for SEM were Wxed in 1% (v/v) buVered glutaraldehyde and 0.1% (v/v) buVered formaldehyde for 30 min and 24 h, respectively. After dehydration with a graded ethanol series, the samples were air-dried. The dried samples were mounted on aluminum supports and sputter coated with gold. The samples were visualized using a scanning electron microscope (JOEL, model JSM-35, Peabody, MA) with a voltage of 25-kV.
Biomechanical studies
Mechanical properties of the engineered testicular prostheses were assessed using a mechanical tester (model 5542, Instron corp., Canton, MA) with a 500-N maximum load cell (n = 3). The longitudinal axis of the specimens was compressed until it reached 80% of the initial thickness and released to its initial position at a cross-head speed of 0.5 in./min. The compressive modulus was obtained from the slope of the initial linear section of the stress-strain curve.
Collagen content assay
The total collagen content per unit dry weight of the engineered prosthesis samples was determined (n = 3 per time point). BrieXy, the retrieved tissue samples were lyophilized, homogenized and hydrolyzed (6 N HCl at 130°C for 3 h) to obtain tissue extracts. After neutralization with 2.5 N NaOH, hydroxyproline oxidation was initiated by adding 1 ml chloramine-T to the extract. After gentle mixing and incubation for 20 min, the chloramine-T was destroyed by the addition of 1 ml perchloric acid to each tube. Finally, 1 ml p-dimethylamino-benzaldehyde solution was added and incubated for color development. The absorbance was measured using a spectrophotometer at 550 nm. The standard curve was plotted using a linear regression analysis.
Hormone detection assay
Testosterone levels, contained in the collected samples, were determined by radioimmunoassay [30] [31] [32] using the procedures supplied by the manufacturer followed by measuring the testosterone levels in an automatic gamma counter (Lbk Wallac, Monterey, CA).
Results
In vivo cartilage formation
All animals tolerated the implants for the entire duration of the study without any noticeable complications. Gross examination at retrieval showed the presence of wellformed milky white cartilage structures within the scrotum (Fig. 1) . There was no evidence of erosion or infection in any of the implantation sites. The average wet and dry weight of the retrieved specimens increased gradually until 3 months, and remained constant at 6 months after implantation.
Compressive biomechanical analyses of the retrieved prostheses demonstrated that the engineered cartilaginous tissue was readily elastic and can withstand high degrees of pressure. The compression modulus, obtained from the slope of the initial linear section of the stress-strain curve was 0.22, 0.49, 0.8, 1.47 and 1.67 kgf at 1, 2, 3 and 6 months, respectively (Fig. 2) .
SEM of the pre-implanted cell polymer scaVolds demonstrated uniform cell attachment on the polymer Wbers (Fig. 3) . The cartilage prostheses retrieved at 1 month after implantation demonstrated the formation of extracellular matrices, which occupied interWbrillar space within the polymer scaVolds. Undegraded polymer Wbers were evident at 1 month. However, solid cartilage tissue structure was present by 3 months after implantation.
Histologically, all of the experimental specimens seeded with cells demonstrated mature chondrocytes accompanied by a basophilic extracellular tissue matrix at all time points (Fig. 4) . Presence of undegraded polymer Wbers was evident at 1 month after implantation and these Wbers continued to degrade over time. The control scaVolds without cells failed to show cartilage tissue formation at all time points. Aldehyde fuschin-alcian blue, toluidine blue, Safranin-O and Masson's trichrome staining further conWrmed that the scaVolds contained cartilage tissue with normal composition and structure.
Collagen content assay demonstrated that the testicular prostheses seeded with cells had an average collagen composition fraction of 6.5 and 10.8% of the total dry weight at 1 and 2 months, respectively. The collagen content then remained constant up to 6 months after implantation (Fig. 5) . Collagen was not detected in control implants without cells.
Testicular prosthesis: in vitro functional studies
In the bioreactor studies, milky white cartilage was formed on every testicular prosthesis by 4 weeks. The ex vivo prostheses, injected with 100 g testosterone enanthate, produced an initial burst of testosterone in the media, followed by a broad plateau for 16 weeks (>500 ng/dl). After this, testosterone levels gradually decreased until 40 weeks. The detected testosterone levels were physiologic throughout the entire study period (40 weeks) (Fig. 6) . The accumulated amount of the released testosterone was calculated as 60% of the initial injection concentration. Histological analyses of all constructs formed in the Xask bioreactor demonstrated cartilaginous tissue structure composed of mature chondrocytes surrounded by extracellular matrices. Testicular prosthesis: in vivo functional studies All animals tolerated the implants for the entire study period. There was no evidence of erosion or infection in any of the implanted animals. In the animals implanted with testosterone-containing prostheses, the circulating testosterone levels peaked on day 1 and then continued to maintain physiologic levels throughout the entire study period (16 weeks). The control animals that received a single intramuscular injection of testosterone demonstrated bursts in hormone levels during the Wrst 3 weeks and then these levels decreased to castrate level by 7 weeks after administration (Fig. 7) . Histologically, the retrieved testicular implants were composed of an outer layer of mature chondrocytes with a hollow spacious center in each prosthesis (Fig. 4) .
Discussion
The need for adequate reconstruction of both testes in patients with bilateral anorchia cannot be overemphasized, as it is critically associated with normal psychosexual development [1, 5, 11] . Although the FDA approved salineWlled silicone prostheses are known to be safer than previous versions (silicone gel-Wlled), the long-term outcome has not been veriWed [33] . In addition to prosthetic implantation, testosterone supplementation is usually necessary to achieve and maintain secondary sexual characteristics [13, 14] . In this study, we show that engineering of cartilaginous testicular prostheses using biodegradable polymers seeded with chondrocytes is possible [23, 25, 34] . We also demonstrate that a large amount of testosterone can be loaded within the engineered tissue and then released over time. These Wndings demonstrate that a tissue-engineered, multi-functional testicular device is able to maintain physiologic levels of serum testosterone for 16 weeks when implanted in the scrotum of castrated animals.
The prosthetic tissue engineered with chondrocytes has several advantages over the synthetic saline-Wlled silicone prostheses. If this technology was used with autologous cells in a clinical setting, the engineered tissue would be biocompatible, non-immunogenic and non-antigenic, thus eliminating some of the problems associated with silicone implantation. This has been tested and conWrmed repeatedly in many experimental and clinical studies using autologous cell-based applications [25-27, 29, 35, 36] . In this study, we have demonstrated that none of the animals experienced adverse eVects resulting from the engineered prosthesis, and all animals survived for the entire duration of the study. In addition, the engineered cartilaginous testis possessed the desired mechanical characteristics, including innate elasticity and resistance to compressive forces. Therefore, problems such as prosthesis rupture or erosion would be unlikely to occur in vivo.
The use of synthetic polymers as cell carriers and support matrices is attractive because they can be degraded in a controlled manner [27, 28] . Here, we used polymer scaVolds that are designed to degrade over a period of 2-3 months, which provided adequate time for tissue formation while maintaining structural integrity. The structural architecture of the Xexible polymer scaVolds was strengthened in this study by the addition of a liqueWed copolymer (poly-L-lactide-co-glycolide 50:50), and, as the Wbers were designed to degrade within 2-3 months, cartilage tissues consisting entirely of cellular components eventually formed. Moreover, maintenance of prosthetic tissue shape and size is required and it largely depends on the structural conWguration of the polymer scaVolds. As such, polymers with 95% porosity and adequate interWbrillar distance were used in this study to promote diVusion and to provide suYcient cell accommodation. As a result, these cartilage tissues engineered in vivo maintained their initial shape and size over time.
Cartilage tissue is best characterized as an avascular structure with abundant extracellular matrix [27, 28] . The seeded chondrocytes readily adhered to the polymer Wbers and progressively formed mature cartilage tissue in vitro and in vivo, replacing the degrading polymer Wbers over time, as demonstrated by scanning electron microscopy. Adequate formation of mature cartilage was achieved, as evidenced by the presence of chondrocytes within lacunae and the presence of highly sulfated mucopolysaccharides. In this study, extracellular matrix was also formed within the engineered prosthesis and consisted mainly of collagen. The amount of collagen production progressively increased up to 2 months and then remained constant, which indicates the stability of the extracellular matrix.
In this study, we show that the testosterone, placed in the central hollow space of the engineered prosthesis, was released over the entire study period (40 weeks ex vivo and 16 weeks in vivo). Although this study did not investigate the exact mechanism of testosterone release, we believe that the release was facilitated by passive diVusion, similar to the way in which mature chondrocytes obtain oxygen and nutrients [26, 28] . If this was correct, the release kinetics of testosterone would be aVected by polymer design and conWguration, cell seeding density, and initial testosterone concentration. However, conWrmation of the release mechanism is critical for optimization of the control of testosterone release through the prosthetic wall over a target period.
In addition, we have shown that the engineered cartilaginous testicular prostheses are able to release testosterone over a longer period of time than a single intramuscular injection of testosterone enanthate, which only lasts up to 7 weeks. More importantly, the serum testosterone levels of the testosterone enanthate injection group were uncontrolled, with a rapid decrease in a linear fashion. These results are consistent with the clinical limitations of intramuscular injection of testosterone enanthate. These include frequent injections and an initial high testosterone bursting eVect that can lead to gynecomastia [17] . In contrast, the engineered prostheses resulted in a lower initial testosterone bursting eVect followed by maintenance of physiologic levels of serum testosterone.
This study clearly demonstrates that the engineered functional testicular prostheses oVer advantages over the currently practiced therapies. The engineered tissue prostheses may augment the limitations and deWciencies of the current testosterone delivery methods. This technology could be used in patients who require testicular prostheses and testosterone supplementation. Autologous cartilage tissue could be obtained from a small biopsy in the outpatient clinic. Chondrocytes from this biopsy would be grown, expanded and seeded on pre-conWgured, computer generated 3D polymer scaVolds. The testicular cartilage prostheses with an internal testosterone reservoir would be constructed ex vivo and then implanted into the same patient. This technology has the potential to become the preferred clinical management tool for anorchia and other disorders requiring testicular prosthesis application with testosterone supplementation. Further studies are currently being performed to optimize the testosterone release system for enhanced control, which is a necessary step for clinical application.
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